YU76601A - Novi kristalni oblici makrolidnog antibiotika - Google Patents

Novi kristalni oblici makrolidnog antibiotika

Info

Publication number
YU76601A
YU76601A YU76601A YUP76601A YU76601A YU 76601 A YU76601 A YU 76601A YU 76601 A YU76601 A YU 76601A YU P76601 A YUP76601 A YU P76601A YU 76601 A YU76601 A YU 76601A
Authority
YU
Yugoslavia
Prior art keywords
crystalline forms
novel crystalline
macrolide antibiotic
forms
macrolide
Prior art date
Application number
YU76601A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Robert John Rafka
Douglas John Meldrum Allen
Colman Brendan Ragan
Barry James Morton
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of YU76601A publication Critical patent/YU76601A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
YU76601A 1999-05-18 2000-04-14 Novi kristalni oblici makrolidnog antibiotika YU76601A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13464499P 1999-05-18 1999-05-18

Publications (1)

Publication Number Publication Date
YU76601A true YU76601A (sh) 2004-09-03

Family

ID=22464300

Family Applications (1)

Application Number Title Priority Date Filing Date
YU76601A YU76601A (sh) 1999-05-18 2000-04-14 Novi kristalni oblici makrolidnog antibiotika

Country Status (43)

Country Link
US (1) US6583274B1 (enExample)
EP (1) EP1189912B1 (enExample)
JP (1) JP3897983B2 (enExample)
KR (1) KR100474229B1 (enExample)
CN (1) CN1203084C (enExample)
AP (1) AP2001002325A0 (enExample)
AR (1) AR020030A1 (enExample)
AT (1) ATE392427T1 (enExample)
AU (1) AU772283B2 (enExample)
BG (1) BG106150A (enExample)
BR (1) BR0011300A (enExample)
CA (1) CA2372206C (enExample)
CZ (1) CZ20014120A3 (enExample)
DE (1) DE60038610T2 (enExample)
DK (1) DK1189912T3 (enExample)
DZ (1) DZ3043A1 (enExample)
EA (1) EA003417B1 (enExample)
ES (1) ES2302689T3 (enExample)
GT (1) GT200000072A (enExample)
HK (1) HK1045521B (enExample)
HN (1) HN2000000056A (enExample)
HR (1) HRP20010849A2 (enExample)
HU (1) HUP0201341A3 (enExample)
IL (2) IL145946A0 (enExample)
IS (1) IS6127A (enExample)
MA (1) MA26735A1 (enExample)
MX (1) MXPA01011914A (enExample)
MY (1) MY133397A (enExample)
NO (1) NO320195B1 (enExample)
NZ (1) NZ514765A (enExample)
OA (1) OA11876A (enExample)
PA (1) PA8495001A1 (enExample)
PE (1) PE20010151A1 (enExample)
PL (1) PL353316A1 (enExample)
PT (1) PT1189912E (enExample)
SK (1) SK16472001A3 (enExample)
TN (1) TNSN00103A1 (enExample)
TW (1) TWI225066B (enExample)
UA (1) UA67842C2 (enExample)
UY (1) UY26144A1 (enExample)
WO (1) WO2000069874A1 (enExample)
YU (1) YU76601A (enExample)
ZA (1) ZA200109420B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
BRPI0017013B8 (pt) * 2000-01-27 2022-11-16 Pfizer Prod Inc composição de antibiótico azalídeo e método para sua obtenção
BR0209241A (pt) * 2001-04-27 2004-06-15 Pfizer Prod Inc Processo para preparação de derivados de9-deoxo-9a-aza-9a-homoeritromicina a 4-substituida
EP1435359A1 (en) * 2002-12-31 2004-07-07 Alembic Limited A process for the purification of roxithromycin
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
EP2384333B1 (en) * 2009-01-30 2013-04-17 Glaxo Group Limited Anti-inflammatory macrolide
EP2402355A1 (en) * 2010-07-01 2012-01-04 Novartis AG Crystalline anhydrous forms II and III of Tulathromycin
EP2736915A1 (en) 2011-07-27 2014-06-04 Farma GRS, d.o.o. New crystalline forms of tulathromycin
CN106008622A (zh) * 2016-08-02 2016-10-12 海门慧聚药业有限公司 泰拉霉素新晶型及其制备
CN109942652B (zh) * 2017-12-21 2022-04-26 洛阳惠中兽药有限公司 一种莱柯霉素晶型ⅰ及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2066324C1 (ru) * 1987-07-09 1996-09-10 Пфайзер Инк. Кристаллический дигидрат азитромицина и способ его получения
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
US5844105A (en) * 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.

Also Published As

Publication number Publication date
US6583274B1 (en) 2003-06-24
EA003417B1 (ru) 2003-04-24
AU772283B2 (en) 2004-04-22
AR020030A1 (es) 2002-03-27
HUP0201341A2 (en) 2002-08-28
ES2302689T3 (es) 2008-08-01
EA200100984A1 (ru) 2002-06-27
CA2372206C (en) 2006-01-10
MY133397A (en) 2007-11-30
HUP0201341A3 (en) 2003-03-28
CN1203084C (zh) 2005-05-25
HK1045521B (zh) 2005-12-09
ATE392427T1 (de) 2008-05-15
PL353316A1 (en) 2003-11-17
KR100474229B1 (ko) 2005-03-08
KR20020007415A (ko) 2002-01-26
JP2002544283A (ja) 2002-12-24
EP1189912A1 (en) 2002-03-27
BG106150A (bg) 2002-05-31
ZA200109420B (en) 2002-11-15
UA67842C2 (uk) 2004-07-15
PT1189912E (pt) 2008-05-16
AP2001002325A0 (en) 2001-12-31
JP3897983B2 (ja) 2007-03-28
DE60038610D1 (de) 2008-05-29
MA26735A1 (fr) 2004-12-20
DZ3043A1 (fr) 2004-03-27
DE60038610T2 (de) 2009-06-25
PA8495001A1 (es) 2002-02-21
IS6127A (is) 2001-10-26
CN1351607A (zh) 2002-05-29
TWI225066B (en) 2004-12-11
WO2000069874A1 (en) 2000-11-23
GT200000072A (es) 2001-11-08
HRP20010849A2 (en) 2003-04-30
CA2372206A1 (en) 2000-11-23
DK1189912T3 (da) 2008-06-30
EP1189912B1 (en) 2008-04-16
UY26144A1 (es) 2000-12-29
CZ20014120A3 (cs) 2003-01-15
HK1045521A1 (en) 2002-11-29
NO20015598D0 (no) 2001-11-16
IL145946A (en) 2007-06-17
NO320195B1 (no) 2005-11-14
NO20015598L (no) 2002-01-08
IL145946A0 (en) 2002-07-25
AU3572900A (en) 2000-12-05
PE20010151A1 (es) 2001-02-08
NZ514765A (en) 2004-05-28
TNSN00103A1 (fr) 2005-11-10
OA11876A (en) 2006-03-27
SK16472001A3 (sk) 2003-02-04
HN2000000056A (es) 2001-02-02
MXPA01011914A (es) 2002-05-06
BR0011300A (pt) 2002-02-26

Similar Documents

Publication Publication Date Title
MEP24608A (en) Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
HUP0302435A2 (hu) 11-Béta-hidroxiszteroid dehidrogenáz 1 típusú enzimet gátló anyagok és ezeket tartalmazó gyógyszerkészítmények
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
BR9914221B1 (pt) Derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
EA199900937A1 (ru) Фармацевтические композиции, содержащие вориконазол
EA199901016A1 (ru) 9-оксим-производные эритромицина
MX9300278A (es) Compuestos de arilalcoxifenoxi-imidazolina.
NO20020282L (no) Nytt difenyl-piperidinderivat
YU76601A (sh) Novi kristalni oblici makrolidnog antibiotika
DE60301339D1 (de) Pyrazolopyrimidin- und pyrazolotriazinderivate und diese enthaltende pharmazeutische zubereitungen
BR0314363A (pt) Indóis 2,4-substituìdos e seu uso como moduladores de 5-ht6
IL173810A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
AP9801377A0 (en) Tricyclic erythromycin derivatives.
SE9902551D0 (sv) Novel compounds
DE69330601D1 (de) Serotoninergische ergolin derivate
YU31995A (sh) Benzotiofeni glikopiranozida, postupak za njihovo dobijanje i njihova farmaceutska formulacija
SE9904128D0 (sv) Novel compounds
IL173895A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
IL173809A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
EA200600022A1 (ru) Применение производных бицикло [2.2.1] гептана для приготовления нейропротекторных фармацевтических композиций
DE60119383D1 (de) Farnesyltransferasehemmende 4-heterocyclylchinolin- und chinazolinderivate
AR022718A1 (es) 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-olessustituidos con n-(5-fenil-tetrahidrofuranil)metilo y n-(6-fenil-tetrahidropiranil)metilo;procedimientos para prepararlos y su empleo como composiciones farmaceuticas.
DE60008430D1 (de) Verbindungen mit antithrombotischer wirkung
ATE180406T1 (de) Erythromycinderivate
SE9902147L (sv) Nya föreningar och farmaceutiska kompositioner innehållande desamma